About Algenex
Algenex is a company based in Madrid (Spain) founded in 2005.. Algenex has raised $13.28 million across 2 funding rounds from investors including Columbus Venture Partners and Vita Advisory. Algenex offers products and services including Top-Bac® and CrisBio®. Algenex operates in a competitive market with competitors including Core Biogenesis, Qkine, Future Fields, Protera and Icon Genetics, among others.
- Headquarter Madrid, Spain
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Algenex Sl
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.28 M (USD)
in 2 rounds
-
Latest Funding Round
$8.75 M (USD), Series B
Sep 08, 2020
-
Investors
Columbus Venture Partners
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Algenex
Algenex offers a comprehensive portfolio of products and services, including Top-Bac® and CrisBio®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Boosts recombinant biologics production using Baculovirus systems.
Enables scalable protein production for health and diagnostics applications.
Funding Insights of Algenex
Algenex has successfully raised a total of $13.28M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $8.75 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $8.8M
-
First Round
First Round
(06 Mar 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Series B - Algenex | Valuation | Columbus Venture Partners |
|
| Mar, 2019 | Amount | Series A - Algenex | Valuation | Vita Advisory |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Algenex
Algenex has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Columbus Venture Partners and Vita Advisory. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Columbus Venture Partners is focused on biotechnology investment funds.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Algenex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Algenex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Algenex Comparisons
Competitors of Algenex
Algenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Core Biogenesis, Qkine, Future Fields, Protera and Icon Genetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
UBaaS platform for plant-based recombinant protein bioproduction is offered.
|
|
| domain | founded_year | HQ Location |
Animal-free growth factors are developed for life science applications.
|
|
| domain | founded_year | HQ Location |
Serum-free bioactive growth factors and recombinant proteins are biomanufactured.
|
|
| domain | founded_year | HQ Location |
Protein-based enzyme technologies are developed using deep learning algorithms.
|
|
| domain | founded_year | HQ Location |
Biopharmaceuticals and proteins are developed using green plants as hosts.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Algenex
Frequently Asked Questions about Algenex
When was Algenex founded?
Algenex was founded in 2005 and raised its 1st funding round 14 years after it was founded.
Where is Algenex located?
Algenex is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Is Algenex a funded company?
Algenex is a funded company, having raised a total of $13.28M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.53M, raised on Mar 06, 2019.
What does Algenex do?
Algenex was founded in 2005 in Madrid, Spain, within the biotechnology sector. Recombinant biologics for animal and human health are produced through a baculovirus expression vector system. Platforms such as Top-Bac, which enhances protein quality via a proprietary cassette, and IBES, utilizing insect larvae as bioreactors, are employed. Resulting proteins support vaccines, diagnostic reagents, and therapeutic molecules.
Who are the top competitors of Algenex?
Algenex's top competitors include Future Fields, Qkine and Oxford Expression Technologies.
What products or services does Algenex offer?
Algenex offers Top-Bac® and CrisBio®.
Who are Algenex's investors?
Algenex has 2 investors. Key investors include Columbus Venture Partners, and Vita Advisory.